Quantum Biopharma (NASDAQ:QNTM) Issues Earnings Results

Quantum Biopharma (NASDAQ:QNTM) issued its quarterly earnings results on Friday. The company reported ($2.89) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($2.09), Zacks reports.

Quantum Biopharma Stock Performance

Shares of QNTM stock traded up $3.86 during midday trading on Friday, reaching $12.24. 7,510,246 shares of the company were exchanged, compared to its average volume of 1,179,892. The company’s 50 day moving average price is $6.09 and its two-hundred day moving average price is $5.01. The company has a market cap of $23.48 million, a P/E ratio of -0.76 and a beta of 0.37. Quantum Biopharma has a 12 month low of $2.70 and a 12 month high of $18.00.

About Quantum Biopharma

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.